EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 46 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,126,597 | +60.9% | 408,574 | +58.0% | 0.01% | +66.7% |
| Q3 2022 | $2,565,000 | +1.6% | 258,574 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $2,525,000 | +0.4% | 258,174 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $2,515,000 | -34.1% | 258,174 | -34.5% | 0.00% | -33.3% |
| Q4 2021 | $3,819,000 | +72.4% | 394,159 | +72.1% | 0.00% | +50.0% |
| Q3 2021 | $2,215,000 | +587.9% | 229,030 | +587.1% | 0.00% | – |
| Q2 2021 | $322,000 | – | 33,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |